Vaginal Dryness After Menopause Is Common—and Treatable

If you are going through perimenopause or are postmenopausal and have noticed vaginal dryness, burning, itching, irritation, painful sex, or new urinary symptoms, you are not alone.

These symptoms are often caused by a condition called genitourinary syndrome of menopause (GSM). GSM describes changes involving the vagina, vulva, urethra, and bladder that occur as estrogen and other sex hormone levels decline during and after menopause.

Unlike hot flashes, which often improve with time, GSM symptoms can persist or become more noticeable over time without treatment. The symptoms can affect sexual comfort, urinary health, sleep, relationships, and overall quality of life. 

The good news is that there are several effective treatments, ranging from over-the-counter vaginal moisturizers and lubricants to prescription therapies.

What Is Genitourinary Syndrome of Menopause (GSM)?

Genitourinary syndrome of menopause, or GSM, is the medical term for a group of genital, sexual, and urinary symptoms related to the decline in estrogen and other sex hormones around menopause.

Estrogen helps maintain the thickness, elasticity, moisture, and blood flow of vaginal and vulvar tissues. It also plays an important role in the tissues of the urethra and lower urinary tract.

As estrogen levels decline, these tissues can become:

• Thinner
• Drier
• Less elastic
• More easily irritated
• Less well lubricated
• More susceptible to discomfort and urinary symptoms

GSM can begin during perimenopause, although some women do not notice symptoms until several years after their final menstrual period. Symptoms may be more pronounced after surgical menopause, certain cancer treatments, or treatment with aromatase inhibitors.

Common Symptoms of GSM

GSM can affect more than vaginal moisture. Symptoms may involve the vulva, vagina, sexual function, bladder, and urethra.

Vaginal and vulvar symptoms

• Vaginal dryness
• Burning or irritation
• Vaginal or vulvar itching
• Decreased natural lubrication
• Vaginal tenderness
• Increased sensitivity or discomfort

Sexual symptoms

• Pain during sexual activity
• Pain with vaginal penetration
• Discomfort that continues after sex
• Light bleeding or spotting after intercourse
• Reduced sexual comfort or satisfaction

Urinary symptoms

• Burning with urination
• Urinary urgency
• Needing to urinate more frequently
• Recurrent urinary tract infections (UTIs)
• Increased sensitivity around the urethra

Not every woman experiences all of these symptoms. For some women, vaginal dryness is the main concern. For others, urinary symptoms or painful sex may be more noticeable.

Why Does Vaginal Dryness Get Worse After Menopause?

The decline in estrogen changes the vaginal environment.

The vaginal tissue becomes thinner and less elastic, and natural lubrication decreases. The normal vaginal environment can also change, including an increase in vaginal pH.

Over time, this can make everyday activities—such as intercourse, pelvic examinations, wiping after urination, or wearing certain clothing—uncomfortable for some women.

This is why GSM is considered a chronic condition rather than simply a temporary symptom of menopause. Without treatment, symptoms often persist and may gradually become more bothersome.

How Is GSM Diagnosed?

In many cases, GSM can be diagnosed based on your symptoms, medical history, and a pelvic examination.

Your OB-GYN may ask about:

• Vaginal dryness or irritation
• Pain during sex
• Urinary urgency or frequency
• Recurrent UTIs
• Bleeding or spotting
• Medications
• Menopause history
• Previous cancer treatment
• Previous hormone therapy

A pelvic examination may help identify thinning, dryness, irritation, tissue changes, or other conditions that can cause similar symptoms.

Hormone blood tests are usually not necessary to diagnose typical GSM in a postmenopausal woman.

It is also important not to automatically assume that every vaginal symptom is caused by menopause. Yeast infections, bacterial vaginosis, dermatologic conditions, sexually transmitted infections, pelvic floor problems, and other conditions can cause similar symptoms.

Treatment for Vaginal Dryness After Menopause

Treatment is individualized. Many women can start with simple non-hormonal measures, while others benefit from prescription therapy.

Step 1: Vaginal Moisturizers and Lubricants

For mild symptoms, vaginal moisturizers and lubricants are often a reasonable starting point.

Vaginal moisturizers

Vaginal moisturizers are used regularly—often several times a week rather than only during sexual activity—to help improve ongoing dryness and discomfort.

Vaginal lubricants

Lubricants are used during sexual activity to reduce friction and discomfort.

Water-based and silicone-based products are commonly used. If you are sensitive to certain ingredients, your clinician can help you choose an appropriate product.

It is important to understand the difference:

Moisturizers are for ongoing vaginal comfort. Lubricants are primarily for reducing friction during sex.

These products can be very helpful for mild symptoms, but they do not reverse the underlying tissue changes caused by estrogen deficiency.

Step 2: Low-Dose Vaginal Estrogen

When moisturizers and lubricants are not enough, low-dose vaginal estrogen is one of the most effective treatments for GSM.

Vaginal estrogen is available in several forms, including:

• Vaginal cream
• Vaginal tablet or insert
• Vaginal ring

Unlike systemic hormone therapy, which is designed to deliver hormone throughout the body, low-dose vaginal estrogen is placed directly in the vagina.

Very little estrogen reaches the bloodstream with many low-dose vaginal preparations, allowing treatment to focus primarily on the vaginal and lower urinary tissues. The Menopause Society describes low-dose vaginal estrogen as an effective treatment for GSM, and FDA labeling for vaginal estrogen products has been updated in recent years to better distinguish local vaginal therapy from systemic hormone therapy.

Vaginal estrogen can improve:

• Vaginal dryness
• Burning and irritation
• Vaginal tissue health
• Lubrication
• Pain with sexual activity
• Some urinary symptoms

It may also help reduce recurrent urinary tract infections in appropriate postmenopausal patients.

Does vaginal estrogen count as hormone therapy?

Yes, vaginal estrogen is an estrogen-containing prescription treatment, but low-dose vaginal estrogen is different from systemic hormone therapy used to treat hot flashes and other whole-body menopausal symptoms.

That distinction is important when discussing safety and treatment options with your clinician.

Step 3: Other Prescription Treatments

If vaginal estrogen is not appropriate, not preferred, or does not provide adequate relief, other prescription options may be considered.

Vaginal DHEA (Prasterone)

Prasterone, also called vaginal DHEA, is a prescription vaginal insert used for moderate-to-severe pain during sexual activity associated with menopause.

It works locally within vaginal tissues and is another option for women with GSM.

Ospemifene

Ospemifene is a daily oral medication classified as a selective estrogen receptor modulator (SERM). It is FDA-approved for moderate-to-severe vaginal dryness and pain associated with sexual activity due to menopausal changes.

Because ospemifene is an oral systemic medication, its risks and contraindications differ from those of low-dose local vaginal estrogen. Your medical history—including a history of blood clots, stroke, certain cancers, or unexplained vaginal bleeding—should be reviewed before treatment.

What About Vaginal Estrogen After Breast Cancer?

This is an important and highly individualized question.

Women with a history of breast cancer or another hormone-sensitive cancer should discuss GSM treatment with their gynecologist and, when appropriate, their oncology team.

Non-hormonal moisturizers and lubricants may be tried first. For women whose symptoms remain bothersome, the potential benefits and risks of local hormonal treatment need to be considered in the context of the individual’s cancer history and current treatment.

This is especially important for women taking aromatase inhibitors, because GSM symptoms may be more pronounced and treatment decisions can be more complex.

The goal is not to automatically rule out treatment—but to choose the safest appropriate option for the individual.

Can GSM Cause Urinary Problems and Recurrent UTIs?

Yes.

GSM can affect the urethra and bladder as well as the vagina and vulva. Women may experience:

• Urinary urgency
• Increased frequency
• Burning with urination
• Recurrent UTIs

Urinary symptoms during menopause should not automatically be attributed to aging. They deserve appropriate evaluation because infections and other urinary conditions can cause similar symptoms.

For women with recurrent UTIs associated with menopause, vaginal estrogen may be part of a prevention strategy when medically appropriate.

What About Vaginal Laser or Radiofrequency Treatments?

Energy-based treatments—including some laser and radiofrequency procedures—have received attention as treatments for vaginal symptoms after menopause.

Research is continuing, and some newer studies have reported improvements in vaginal or sexual symptoms with certain technologies. However, these treatments should not automatically be considered equivalent to established therapies such as vaginal estrogen or other FDA-approved treatments.

If you are considering a vaginal energy-based procedure, ask what evidence supports the specific device, what risks are known, and whether established treatments may be appropriate first.

When Should You See an OB-GYN?

Make an appointment if you have:

• Any vaginal bleeding after menopause
• Persistent vaginal dryness or burning
• Pain during sex
• Vaginal symptoms that do not improve with moisturizers or lubricants
• Recurrent urinary tract infections
• Burning or pain with urination
• New urinary urgency or frequency
• Symptoms affecting intimacy, sleep, relationships, or quality of life

Postmenopausal bleeding deserves special attention.

Even a small amount of bleeding or spotting after menopause should be evaluated rather than automatically attributed to vaginal dryness.

The cause may be something relatively simple, such as fragile vaginal tissue, but postmenopausal bleeding can also be associated with abnormalities of the uterus or cervix that need evaluation.

The Bottom Line

Vaginal dryness after menopause is common, but it is not something you simply have to live with.

Genitourinary syndrome of menopause can cause vaginal dryness, burning, itching, painful sex, urinary urgency, recurrent UTIs, and other symptoms that affect everyday life.

Treatment can begin with vaginal moisturizers and lubricants and, when needed, progress to prescription options such as low-dose vaginal estrogen, vaginal DHEA, or ospemifene.

The right treatment depends on your symptoms, medical history, medications, cancer history, urinary symptoms, and personal preferences.

A conversation with an experienced OB-GYN can help determine whether your symptoms are related to GSM and which treatment approach makes sense for you.